How are esophageal motility disorders (achalasia, distal esophageal spasm, hypercontractile (jackhammer) esophagus, and ineffective esophageal motility) diagnosed and managed?

Diagnosis and Management of Esophageal Motility Disorders

Esophageal manometry is the definitive diagnostic test for esophageal motility disorders and should be performed after excluding mechanical obstruction with endoscopy or barium esophagram 1.

Diagnostic Approach

Initial Evaluation

When a patient presents with dysphagia, regurgitation, or chest pain:

• First-line testing: Perform esophagogastroduodenoscopy (EGD) to exclude structural abnormalities (strictures, tumors, esophagitis) 1
• Barium esophagram: Use as complementary imaging to identify mechanical obstruction before proceeding to manometry 1
• High-resolution manometry (HRM): This is the gold standard for diagnosing motility disorders once obstruction is excluded 1, 2

Key Diagnostic Metrics

HRM with Chicago Classification (version 4.0) evaluates:

• Integrated relaxation pressure (IRP): Measures lower esophageal sphincter (LES) relaxation
• Distal contractile integral (DCI): Assesses esophageal body contractility
• Distal latency (DL): Evaluates timing of contractions 3

Common Pitfall

Do not use manometry as the initial test for chest pain or dysphagia due to low specificity—always exclude mechanical causes first 1.

Management by Specific Disorder

Achalasia (Types I, II, III)

The Chicago Classification divides achalasia into three subtypes based on esophageal body pressurization patterns, which directly impacts treatment selection 4.

Type I and II Achalasia

For Type I and II achalasia, pneumatic dilation (PD) and laparoscopic Heller myotomy (LHM) are equally effective first-line treatments 4.

Treatment algorithm:

• Pneumatic dilation: Lower morbidity and cost; expect need for repeat dilations over years 4
• Laparoscopic Heller myotomy: Equivalent 5-year outcomes to PD 4
• POEM (per-oral endoscopic myotomy): Consider as alternative to LHM if expertise available, but expect higher reflux rates 4

Type III Achalasia (Spastic Achalasia)

POEM is the preferred treatment for Type III achalasia because it allows calibration of myotomy length to the spastic segment 4.

• Type III has obstructive contractility of the distal esophagus requiring longer myotomy (average 17.2 cm) 4
• Response rate: 92% (95% CI: 84-96%) 4
• Calibrate myotomy length using HRM findings or esophageal wall thickening on endoscopic ultrasound 4
• Traditional therapies (PD, LHM) have less robust outcomes in Type III 4

Critical consideration: POEM should only be performed by experienced physicians in high-volume centers (20-40 procedures needed for competence) 4.

Post-Treatment Reflux Management

All patients undergoing POEM are at high risk for reflux esophagitis and require indefinite proton pump inhibitor therapy and/or surveillance endoscopy 4. Up to 58% develop gastroesophageal reflux on pH-metry 4.

Distal Esophageal Spasm (DES)

Medical management with smooth muscle relaxants and pain modulators is first-line therapy 5.

• Consider botulinum toxin injection into the esophageal body for refractory cases, though optimal protocols remain undefined 5
• POEM may be considered for severe, refractory cases if expertise available 4

Hypercontractile (Jackhammer) Esophagus

Treat with smooth muscle relaxants and pain modulators as first-line therapy 5.

• Botulinum toxin injection is an emerging option but requires further study 5
• POEM reserved for refractory cases with appropriate expertise 4

Ineffective Esophageal Motility (IEM)

Treatment options are limited and disappointing; focus on dietary modifications and lifestyle changes 5.

• No effective esophageal prokinetic agents currently available 5
• Address underlying causes (rheumatologic diseases, systemic sclerosis) 6
• Manage associated reflux aggressively as impaired clearance worsens symptoms

EGJ Outflow Obstruction

Many cases resolve spontaneously—image the EGJ with endoscopic ultrasound or CT to rule out mechanical obstruction before considering achalasia-type therapies 4.

• Can represent early/incomplete achalasia (12-40% of cases) 4
• Functional luminal imaging probe (FLIP) or esophageal pressurization patterns support achalasia diagnosis 4
• If persistent and symptomatic despite excluding mechanical causes, consider achalasia therapies 4

Special Considerations

Preoperative Assessment for Antireflux Surgery

Manometry is mandatory before antireflux surgery if there is any question of alternative diagnosis, especially achalasia 1. Missing achalasia and performing fundoplication can lead to catastrophic outcomes.

End-Stage Disease

For patients with severe esophageal dilation, sigmoid deformation, or epiphrenic diverticulum:

• POEM has been used successfully but with doubled adverse event rates in sigmoid esophagus 4
• Limited comparative data versus LHM in this population 4
• Most treatment trials excluded end-stage cases 4

Patient-Specific Factors

When selecting treatment, consider 4:

• Chicago Classification subtype
• Comorbidities
• Early versus late disease stage
• Presence of hiatal hernia (increases post-POEM reflux risk)
• Local expertise availability